SGN-MesoC2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGN-MesoC2, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]